Delfi Diagnostics - About the company
Delfi Diagnostics is a series B company based in Baltimore (United States), founded in 2019 by Victor Velculescu. It operates as a Provider of DNA sequencing for cancer detection. Delfi Diagnostics has raised $332M in funding from investors like Orbimed, DFJ Growth and Merck Global Health Innovation Fund. The company has 499 active competitors, including 153 funded and 111 that have exited. Its top competitors include companies like Guardant Health, Natera and Myriad Genetics.
Company Details
Provider of DNA sequencing for cancer detection. The company's platform uses artificial intelligence and whole genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients with cancer.
- Website
- delfidiagnostics.com
- Social
- Email ID
- *****@delfidiagnostics.com
- Phone Number
- +1 **********
- Registered Address
- 1999 BRYAN ST STE 900,DALLAS,TX,75201,57
Key Metrics
Founded Year
2019
Location
Baltimore, United States
Stage
Series B
Total Funding
$332M in 6 rounds
Latest Funding Round
Ranked
9th among 499 active competitors
Employee Count
162 as on Mar 31, 2026
Similar Companies
Legal entities associated with Delfi Diagnostics
Delfi Diagnostics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
DELFI DIAGNOSTICS, INC. CIN: 32089374113 , United States, Active | Apr 11, 2023 | - | - | - |
Sign up to download Delfi Diagnostics' company profile
Delfi Diagnostics's funding and investors
Delfi Diagnostics has raised a total funding of $332M over 6 rounds. Its first funding round was on Jun 18, 2018. Delfi Diagnostics has 20 institutional investors.
Here is the list of recent funding rounds of Delfi Diagnostics:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 01, 2025 | 3305518 | Conventional Debt | 1458063 | 9799048 | 5389214 | 2222814 |
Jun 05, 2024 | 1344869 | Series B | 2361850 | 8617327 | 9067779 | 2704973 |
Jul 18, 2022 | 9225874 | Series B | 8557484 | 6619801 |
Access funding benchmarks and valuations. Sign up today!View details of Delfi Diagnostics's funding rounds and investors
Delfi Diagnostics' founders and board of directors
Founder? Claim ProfileThe founders of Delfi Diagnostics is Victor Velculescu. Susan Tousi is the CEO of Delfi Diagnostics.
Here are the details of Delfi Diagnostics' key team members:
- Victor Velculescu: Founder and Board of Directors of Delfi Diagnostics. They serve on the board of 1 company.
- Susan Tousi: CEO of Delfi Diagnostics. Contact Info: 1 email address
Delfi Diagnostics' Board of Directors
Delfi Diagnostics's board has 13 active members. Justin Kao, Victor Velculescu, William Stevens, Rishi Gupta, Greg Yap, Peter Bach, Michael Dybbs, Jennifer Buechel, Jacob Van Naarden, Elizabeth Homans, William J. Stevens, Nicholas Dracopoli and Douglas Schenkel are independent board members.Here is the list of Delfi Diagnostics' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 3y 8m | |
bctnskp | Independent board member | - | Current | 2y 3m |
hkpbjtx | Independent board member | - | Current | 1y 9m |
rdnk{ce | Independent board member | - | Current | 9y 8m |
{akkytj | Independent board member | - | Current | 6y 4m |
cvzsqb{ | Independent board member | - | Current | 9y 9m |
guq{llv | Independent board member | - | Current | 5y 1m |
{cmrlbg | Independent board member | - | Current | 7y 6m |
xyjzfwd | Independent board member | - | Current | 5y 9m |
tgksoss | Independent board member | - | Current | 7y 8m |
vjidnon | Independent board member | - | Current | 9y 3m |
lfkaxdl | Independent board member | - | Current | 9y 2m |
trdnshn | Independent board member | - | Current | 4y 5m |
View details of Delfi Diagnostics's Founder profiles and Board Members
Delfi Diagnostics' employee count trend
Delfi Diagnostics has 162 employees as of Mar 26. Here is Delfi Diagnostics's employee count trend over the years:
Uncover Delfi Diagnostics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Delfi Diagnostics's Competitors and alternates
Top competitors of Delfi Diagnostics include Guardant Health, Natera and Myriad Genetics. Here is the list of Top 10 competitors of Delfi Diagnostics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Guardant Health 2012, Redwood City (United States), Public | Developer of digital sequencing technology for cancer detection | $557M | 80/100 | |
2nd | Natera 2004, Redwood City (United States), Public | Developer of cell-free DNA testing for oncology, women’s health, and organ health | $152M | 77/100 | |
3rd | Myriad Genetics 1991, United States, Public | Developer of molecular diagnostics and personalized medicine for cancer | - | 75/100 | |
4th | Exact Sciences 1995, Madison (United States), Acquired | Provider of non-invasive molecular diagnostic testing solutions for cancer | - | 73/100 | |
5th | Caris Life Sciences 1996, Irving (United States), Public | Developer of panomic disease profiling technologies for cancer precision medicine | $1.23B | 72/100 | |
6th | Online platform for genetic and diagnostic health testing that helps identify health risks | $67.6M | 70/100 | ||
7th | Foundation Medicine 2010, Cambridge (United States), Acquired | Provider of genomics-based diagnostics test for cancer | $96.5M | 70/100 | |
8th | BillionToOne 2015, San Francisco (United States), Public | Provider of cell-free cancer liquid biopsy test | $389M | 69/100 | |
9th | Delfi Diagnostics 2019, Baltimore (United States), Series B | Provider of DNA sequencing for cancer detection | $332M | 68/100 | |
10th |  Foresight Diagnostics 2020, Aurora (United States), Acquired | Developer of minimally-invasive liquid biopsy test for the detection of cancer | $104M | 66/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Delfi Diagnostics's competitors? Click here to see the top ones
Delfi Diagnostics's Investments and acquisitions
Delfi Diagnostics has made no investments or acquisitions yet.
Reports related to Delfi Diagnostics
Here is the latest report on Delfi Diagnostics's sector:
News related to Delfi Diagnostics
Filter this listMedia has covered Delfi Diagnostics for a total of 5 events in the last 1 year, 2 of them have been about company updates and 2 about partnerships.
•
•
Community Capital and Delfi Partner for Integrated Analytics & Loan PlatformBusiness Wire•Oct 01, 2025•Delfi Diagnostics, Access Washington
•
Hanshow and Delfi Partner to Expand Digital Solutions in EuropeBusiness Wire•Sep 15, 2025•Delfi Diagnostics, Hanshow
•
Delfi Launches Optimal Duration Index (ODIN): A New Compass for Lending DecisionsFintech Finance•Sep 12, 2025•Delfi Diagnostics
•
Delfi Labs Chooses William Mills Agency for PRBusiness Wire•Apr 22, 2025•Delfi Diagnostics, William Mills Agency
•
•
•
•
•
Delfi launches cancer-monitoring blood test alongside Immunocore collabFierce Biotech•Feb 01, 2024•Delfi Diagnostics, Immunocore
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Delfi Diagnostics
Explore our recently published companies
- Dl-Dental-2000 - Germany based, Unfunded company
- Kardiokl - Germany based, Unfunded company
- Blk-Care - Unfunded company
- DRPU Software - Ghaziabad based, 2008 founded, Public company
- Independent School District 625 - United States based, Funding Raised company
- Scioto Valley Solar One - Columbus based, 2021 founded, Funding Raised company
